Overview

Propagenix is engaged in the development and commercialization of technology for expanding and differentiating tissue-resident epithelial stem cells from tissues such as skin, airway, kigney and cornea. The company is dedicated to continuing to develop Propagenix technology for a wide range of applications in basic and translational biomedical research. Our vision is to enable the creation of new and more effective drugs, personalized diagnostics and cell therapies that will enhance human healthcare. The team has created a culture that places high value and thrives on scientific excellence, innovation, open and honest communication, a collaborative attitude, and a fast-paced work environment.